Plain English summary not yet available
The full original text is available below. Check back soon as we process this bill.
II
117TH CONGRESS
1ST SESSION
S. 236
To improve activities for the gathering of data on, and the tracking of,
new variants of COVID–19.
IN THE SENATE OF THE UNITED STATES
FEBRUARY 4, 2021
Ms. BALDWIN (for herself, Mr. BROWN, Mrs. FEINSTEIN, Mr. BLUMENTHAL,
Mr. MARKEY, Mr. PETERS, and Ms. KLOBUCHAR) introduced the fol-
lowing bill; which was read twice and referred to the Committee on
Health, Education, Labor, and Pensions
A BILL
To improve activities for the gathering of data on, and the
tracking of, new variants of COVID–19.
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled,
2
SECTION 1. SHORT TITLE.
3
This Act may be cited as the ‘‘Tracking COVID–19
4
Variants Act’’.
5
SEC. 2. FINDINGS.
6
Congress finds that—
7
VerDate Sep 11 2014
22:40 Feb 23, 2021
Jkt 019200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\S236.IS
S236
pamtmann on DSKBC07HB2PROD with BILLS
2
•S 236 IS
(1) new variants of SARS–CoV–2 are being
1
identified around the world and in the United
2
States;
3
(2) identifying new variants of SARS–CoV–2
4
and analyzing the epidemiology of variants are crit-
5
ical to the continued response to the COVID–19
6
pandemic and efforts to prepare for future
7
pandemics;
8
(3) national sequence-based surveillance will en-
9
able the United States to best identify new variants;
10
and
11
(4) the United States is conducting sequence-
12
based surveillance of approximately 0.3 percent of
13
COVID–19 cases, lagging far behind other nations.
14
SEC. 3. GUIDANCE.
15
The Secretary of Health and Human Services (re-
16
ferred to in this Act as the ‘‘Secretary’’), acting through
17
the Director of the Centers for Disease Control and Pre-
18
vention, shall issue national guidance to support scientific
19
collaboration relating to viral sequencing as a key strategy
20
to the COVID–19 response activities of the United States,
21
including guidance related to the sharing of specimens ob-
22
tained from patients, the secure sharing of information
23
about such specimens necessary for an effective public
24
VerDate Sep 11 2014
22:40 Feb 23, 2021
Jkt 019200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\S236.IS
S236
pamtmann on DSKBC07HB2PROD with BILLS
3
•S 236 IS
health response to COVID–19, and the appropriate use
1
of viral sequence data derived from such specimens.
2
SEC. 4. FUNDING FOR GENOMIC SEQUENCING, ANALYTICS,
3
AND DISEASE SURVEILLANCE.
4
(a) IN GENERAL.—The Secretary, acting through the
5
Director of the Centers for Disease Control and Preven-
6
tion, shall establish and implement a program to strength-
7
en and expand activities related to genomic sequencing,
8
analytics, and disease surveillance.
9
(b) USE OF FUNDS.—In implementing the program
10
under subsection (a), the Secretary, acting through the
11
Director of the Centers for Disease Control and Preven-
12
tion, shall—
13
(1) conduct and expand activities, including
14
supporting the Advanced Molecular Detection Pro-
15
gram, to sequence the genome of circulating strains
16
of the SARS–CoV–2 virus, to identify mutations in
17
the SARS–CoV–2 virus, and to survey the circula-
18
tion and transmission of variant strains of the
19
SARS–CoV–2 virus;
20
(2) provide technical assistance and guidance
21
and award grants or cooperative agreements to
22
State, local, Tribal, or territorial public health de-
23
partments to increase the capacity of such depart-
24
ments to sequence the genome of circulating strains
25
VerDate Sep 11 2014
22:40 Feb 23, 2021
Jkt 019200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\S236.IS
S236
pamtmann on DSKBC07HB2PROD with BILLS
4
•S 236 IS
of the SARS–CoV–2 virus, to identify mutations in
1
the SARS–CoV–2 virus, to use genomic sequencing
2
to identify outbreaks and clusters of COVID–19 in-
3
fections caused by specific variants of SARS–CoV–
4
2, and to develop effective COVID–19 response
5
strategies based on genetic sequencing and surveil-
6
lance data; and
7
(3) carry out activities to both enhance the
8
informatics capabilities of the public health work-
9
force and expand the numbers of qualified public
10
health informaticians available to analyze and inter-
11
pret data produced through advanced molecular de-
12
tection and genomic sequencing to establish, expand,
13
or enhance capacity for conducting statistical public
14
health research.
15
(c) IMPLEMENTATION.—
16
(1) COOPERATIVE
AGREEMENTS
FOR
TECH-
17
NICAL
ASSISTANCE.—Cooperative agreements de-
18
scribed in subsection (b)(2) may include partner-
19
ships with academic research institutions.
20
(2) CAPACITY FOR SHARING AND LINKING.—
21
The capacity referred to in subsection (b)(3) may in-
22
clude sharing and linking information and accessing
23
and utilizing linked health data files in accordance
24
with established data use agreements with data hold-
25
VerDate Sep 11 2014
22:40 Feb 23, 2021
Jkt 019200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\S236.IS
S236
pamtmann on DSKBC07HB2PROD with BILLS
5
•S 236 IS
ers (including electronic case reporting, electronic
1
health records, and electronic test orders and re-
2
sults) with public health agencies and related sys-
3
tems, including the National Death Index, immuni-
4
zation information systems, syndromic surveillance
5
systems, laboratory information management sys-
6
tems, electronic case reporting systems, medical ex-
7
aminer case management systems, and Patient Uni-
8
fied Look-up Systems for Emergencies.
9
(d) FACILITIES.—Funds appropriated under sub-
10
section (f) may be used for grants for the construction,
11
alteration, or renovation of non-federally owned facilities
12
to improve genetic sequencing and surveillance capabilities
13
at the State and local level.
14
(e) EXPANSION
OF ONGOING ACTIVITIES.—Funds
15
appropriated under subsection (f) may be used for grants
16
for the maintenance and expansion of current and ongoing
17
activities to analyze and interpret data produced through
18
advanced molecular detection and genomic sequencing, in-
19
cluding for emerging public health threats.
20
(f) AUTHORIZATION OF APPROPRIATIONS.—There is
21
authorized to be appropriated, $2,000,000,000 for fiscal
22
year 2021 to carry out this section, to remain available
23
until expended.
24
VerDate Sep 11 2014
22:40 Feb 23, 2021
Jkt 019200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\S236.IS
S236
pamtmann on DSKBC07HB2PROD with BILLS
6
•S 236 IS
SEC. 5. EVIDENCE-BUILDING DEMONSTRATION PROGRAM.
1
(a) IN GENERAL.—The Secretary, acting through the
2
Director of the National Center for Health Statistics, shall
3
carry out a demonstration program to expand the data
4
linkage program of the Department of Health and Human
5
Services, consisting of Federal statistical and pro-
6
grammatic datasets from specified Federal entities, as au-
7
thorized by subchapter III of chapter 35 of title 44,
8
United States Code, for the purpose of facilitating statis-
9
tical public health research on trends and patterns across
10
specifically defined, statistically relevant populations, with
11
a particular focus on linking social determinants of health
12
data, including with respect to—
13
(1) food insecurity;
14
(2) housing instability;
15
(3) transportation access;
16
(4) safety;
17
(5) social connection and isolation;
18
(6) financial resource strain;
19
(7) stress;
20
(8) race and ethnicity; and
21
(9) sexual orientation and gender identity.
22
(b) ACTIVITIES.—Activities carried out under the
23
demonstration program under this section shall include—
24
(1) assessing the availability of identified and
25
deidentified data sets held by Federal, State, local,
26
VerDate Sep 11 2014
22:40 Feb 23, 2021
Jkt 019200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\S236.IS
S236
pamtmann on DSKBC07HB2PROD with BILLS
7
•S 236 IS
and non-Federal entities that may be useful for re-
1
search described in subsection (a); and
2
(2) using existing authorities and linkages of
3
data in accordance with subchapter III of chapter 35
4
of title 44, United States Code, when relevant to re-
5
quest the submission of datasets to the National
6
Center for Health Statistics for linking.
7
(c) LIMITATION.—The Secretary shall limit access to
8
data under the demonstration program under this sec-
9
tion—
10
(1) to Federal statistical agencies and qualified
11
public and private researchers, as determined by the
12
Director of the National Center for Health Statis-
13
tics;
14
(2) for a period to be specified by the Sec-
15
retary; and
16
(3) exclusively for the purpose described in sub-
17
section (a).
18
(d) PROCESS FOR MAKING DATA AVAILABLE.—
19
(1) IN GENERAL.—Consistent with paragraph
20
(2), the Secretary shall establish a rigorous process
21
for making data available and usable under the dem-
22
onstration program under this section.
23
(2) REQUIREMENTS.—Prior to making any
24
data available under the demonstration program
25
VerDate Sep 11 2014
22:40 Feb 23, 2021
Jkt 019200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\S236.IS
S236
pamtmann on DSKBC07HB2PROD with BILLS
8
•S 236 IS
under this section, by an entity described in sub-
1
section (b)(1) to another entity described in sub-
2
section (b)(1)—
3
(A) the receiving entity shall submit to the
4
Director of the National Center for Health Sta-
5
tistics an application for data for the purpose
6
described in subsection (a); and
7
(B) the Director shall approve or deny
8
such request in writing, including in the case of
9
a denial an explanation of the reasons for the
10
denial.
11
(e) RULEMAKING.—
12
(1) NO
DELAY
ON
IMPLEMENTATION.—The
13
Secretary—
14
(A) shall begin the implementation of the
15
demonstration program under this section upon
16
the date of enactment of this Act; and
17
(B) shall not delay such implementation
18
for purposes of promulgating the regulations re-
19
quired by paragraph (2).
20
(2) PROMULGATION.—The Secretary shall—
21
(A) promulgate regulations for carrying
22
out this section; and
23
(B) specify in such regulations the allowed
24
and disallowed purposes for sharing and linking
25
VerDate Sep 11 2014
22:40 Feb 23, 2021
Jkt 019200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6201
E:\BILLS\S236.IS
S236
pamtmann on DSKBC07HB2PROD with BILLS
9
•S 236 IS
data through the program, including areas of
1
potential research.
2
(f) WEBSITE.—The Secretary shall maintain a pub-
3
licly accessible website—
4
(1) providing information about the demonstra-
5
tion program under this section;
6
(2) facilitating stakeholder participation in such
7
demonstration program;
8
(3) facilitating oversight of such demonstration
9
program;
10
(4) providing lists of datasets from Federal and
11
non-Federal entities;
12
(5) providing lists of identified and deidentified
13
datasets;
14
(6) identifying linked datasets;
15
(7) delineating a process to protect privacy and
16
confidentiality;
17
(8) identifying sources of the datasets; and
18
(9) delineating categories of personal data.
19
(g) PROGRAM REQUIREMENTS.—The demonstration
20
program under this section shall be designed to—
21
(1) support data matching services for agencies
22
and researchers using the National Death Index;
23
and
24
VerDate Sep 11 2014
22:40 Feb 23, 2021
Jkt 019200
PO 00000
Frm 00009
Fmt 6652
Sfmt 6201
E:\BILLS\S236.IS
S236
pamtmann on DSKBC07HB2PROD with BILLS
10
•S 236 IS
(2) facilitate collaboration with States and pri-
1
vate entities to examine, update, and modernize the
2
fee structure of the National Death Index to support
3
a broad range of data queries.
4
(h) CONTRACTED ENTITIES.—
5
(1) IN GENERAL.—Subject to the availability of
6
appropriations, the Secretary may enter into con-
7
tracts with eligible entities, as appropriate, for infra-
8
structure and support services in carrying out the
9
demonstration program under this section.
10
(2) ELIGIBILITY.—To be eligible for a contract
11
under paragraph (1), an entity shall—
12
(A) demonstrate core capabilities for data
13
sharing, data linkage, and compliance with sub-
14
chapter III of chapter 35 of title 44, United
15
States Code; and
16
(B) adhere to security standards in accord-
17
ance with the Federal Risk and Authorization
18
Management Program (or any successor pro-
19
gram).
20
(i) RULE OF CONSTRUCTION.—Nothing in this sec-
21
tion shall be construed to authorize the availability or use
22
of data for—
23
(1) law enforcement; or
24
VerDate Sep 11 2014
22:40 Feb 23, 2021
Jkt 019200
PO 00000
Frm 00010
Fmt 6652
Sfmt 6201
E:\BILLS\S236.IS
S236
pamtmann on DSKBC07HB2PROD with BILLS
11
•S 236 IS
(2) any determination of the eligibility of an in-
1
dividual for any direct or indirect payment, benefit,
2
or service.
3
(j) REPORT TO CONGRESS.—Not later than 1 year
4
after the date of enactment of this Act, and annually
5
thereafter, the Secretary shall submit a report to the Con-
6
gress on the implementation of this section, including—
7
(1) identification of best State practices for—
8
(A) sharing data with, and reporting data
9
to, the National Death Index; and
10
(B) ensuring the quality of such data; and
11
(2) recommendations to improve—
12
(A) such sharing and reporting; and
13
(B) access to the National Death Index by
14
researchers.
15
(k) AUTHORIZATION OF APPROPRIATIONS.—There is
16
authorized to be appropriated to carry out this section,
17
$10,000,000 for fiscal year 2021, to remain available until
18
expended.
19
Æ
VerDate Sep 11 2014
22:40 Feb 23, 2021
Jkt 019200
PO 00000
Frm 00011
Fmt 6652
Sfmt 6301
E:\BILLS\S236.IS
S236
pamtmann on DSKBC07HB2PROD with BILLS
Important: This plain English summary was generated by AI and is provided for informational purposes only.
It is not legal advice. Always consult the official bill text on Congress.gov
or a qualified attorney for legal matters.